HILLARY IWEORAH: Open Payments
NPI 1003574997 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 63 payments from 15 companies in 2025. Trend: 2023 $3,603 · 2024 $2,767 · 2025 $1,922
Food & beverage: $1,922
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $817 |
| GlaxoSmithKline, LLC. | 20 | $395 |
| Verona Pharma, Inc. | 4 | $180 |
| Inspire Medical Systems, Inc. | 8 | $167 |
| Amgen Inc. | 3 | $78 |
| Electromed, Inc. | 4 | $51 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $42 |
| Organogenesis Inc. | 1 | $42 |
| Genentech USA, Inc. | 1 | $35 |
| Intra-Sana Laboratories | 1 | $21 |
Products named: FASENRA, TEZSPIRE, NUCALA, Ohtuvayre, INSPIRE, TRELEGY ELLIPTA, AIRSUPRA, SMARTVEST.
Industry payments across CT — which companies pay providers there.
